CIC biomaGUNE Develops Nanoparticles for Lung Disease Treatment
Basque research institute CIC biomaGUNE has developed a groundbreaking pulmonary surfactant nanoparticle (PSNP) therapy designed to restore lung function in patients with respiratory diseases, including acute respiratory distress syndrome (ARDS) ... Read More